Latest corporate filings — Indian listed companies
11603 filings processed. AI-summarised within seconds of being filed on BSE/NSE.
All
Financial Results
Dividend
Board Meeting
Insider Trading
Corporate Action
Management Change
Merger / Acquisition
IPO / Listing
Buyback
Credit Rating
-
Unaudited Financial Results (Standalone & Consolidated) for the quarter ended 30th June, 2026
Board MeetingBoard meeting to consider Q1FY27 results Date: 10-Aug-2026 (Mon) -
Outcome of Board Meeting
Financial ResultsQ1FY27 results (unaudited): Standalone: Revenue 5.1bn +29% y-y (3.97bn) PAT 0.179bn +6% y-y (0.169bn) Consolidated: Revenue 5.15bn +34% y-y (3.84bn) … -
This is with reference to our intimation dated 6th August, 2026 regarding Earnings Call with the investors on the Unaudi…
Financial ResultsAudio recording of Q1FY27 earnings call uploaded -
Outcome of Board Meeting
Financial ResultsFY2026 results: Standalone: Revenue 2.326tn +x% y-y (2.326tn) PAT 119.2bn +x% y-y (119.2bn) Consolidated: Revenue 2.326tn +x% y-y (2.326tn) PAT 151.6… -
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose he…
General UpdateQ1FY27 earnings call scheduled for 14-Aug-2026 at 18:30 IST -
Newspaper Publication-Financial Results for the Quarter ended 30 June 2026
Financial ResultsQ1FY27 results (unaudited): Consolidated: Revenue 25.4bn +12% y-y (22.7bn) PAT 3.6bn +98% y-y (1.8bn) FY26 results (audited): Consolidated: Revenue 7… -
As per detailed disclosure enclosed
Regulatory ComplianceSecurity Cover Certificate submitted for Non-Convertible Debt Securities as of June 30, 2026 - Certified by B.K. Khare & Co., Chartered Accountants - … -
Outcome of Postal Ballot notice dated June 30, 2026.
Board MeetingOutcome of Postal Ballot for appointment of Non-Executive Nominee Director - Resolution passed on August 7, 2026, by requisite majority - Mr. Sachin R… -
Please find enclosed Press Release - "Wockhardt Antibiotic Academy, an initiative for Patient-Centric Scientific Dialogu…
General UpdateWockhardt launched the Antibiotic Academy to foster scientific dialogue on antimicrobial resistance. The platform aims to educate clinicians across In… -
Please find attached herewith Disclosures regarding Change in Directorate.
Management ChangeChange in Company’s Directorate - Re-appointment of Shri Piyush Mutha as Managing Director for 3 years from 01-Apr-2027 to 31-Mar-2030, subject to AGM… -
Intimation under Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirement…
General UpdateInvestor/analyst meet scheduled for 13-Aug-2026 from 09:00 to 18:00 IST in Mumbai. Management will participate in one-on-one and group meetings at Equ… -
Resignation of Director/KMP/SMP
Management Change🚪 LEADERSHIP RESIGNATION — Liberty Shoes Limited (name not specified) resigned as Director -
Please find enclosed copies of newspaper publication in respect of unaudited results for the quarter ended June 2026.
Financial ResultsPress Release - Q1FY27 - Standalone revenue 21.75bn (+8.5% y-y); consolidated revenue 27.92bn (+13.7% y-y) - Standalone PAT 10.92bn (+47% y-y); consol… -
Outcome of Board Meeting held on August 10, 2026.
Financial ResultsFY2026 results (audited): Standalone: Revenue 7.2bn -12% y-y (8.2bn) EBITDA 1.1bn -6% y-y (1.2bn) EBITDA margin 15.0% (14.8%) +20 bps y-y PAT 0.38bn -… -
Intimation of 44th AGM of the Company to be held on 26/09/2026 (Saturday) at 11.00 AM through Video Conference (VC) mode…
Corporate Action📋 AGM CUT-OFF DATE — TGV Sraac Ltd Record Date: 26-Sep-2026 -
Chairman & Managing Director''s Statement at the 73rd Annual General Meeting of the Company.
Corporate Action73rd Annual General Meeting (AGM) Date: 06-Aug-2026 (Thu), 3:15 PM -
Analysts/Institutional Investor Meet/Con. Call Updates
General UpdateInvestor/analyst meet scheduled for 17-Aug-2026 at Motilal Oswal 22nd Annual Global Investor Conference in Mumbai, India -
Investor Presentation
Financial ResultsInvestor Presentation - Q1FY27 - Consolidated revenue 1,364 Cr, +33% YoY; EBITDA 205 Cr, +51% YoY; EBITDA margin 15.1%, +190 bps YoY - Advanced Plasti… -
The Board of Directors of the Company at its Meeting held today, inter-alia considered and approved the Unaudited Financ…
Financial ResultsQ1FY27 results (unaudited): Standalone: Revenue 2.0bn +10% y-y (1.8bn) PAT 0.096bn +79% y-y (0.054bn) Consolidated: Revenue 2.0bn +10% y-y (1.8bn) PA… -
Press Release- Financial Results for the quarter ended 30th June 2026
Financial ResultsPress Release - Q1FY27 - Revenue 756.3 Cr +37.1% y-y; EBITDA 111.7 Cr +60.7% y-y; PAT 64.5 Cr +89.9% y-y - Pharmaceuticals revenue up 43% y-y; EBIT up… -
Intimation of Group/One-on-One Investor Meeting with Equirus Institutional Investor on 13.08.2026.
General UpdateInvestor/analyst meet scheduled for 13-Aug-2026 in Mumbai with Equirus Institutional Investor -
The Company has informed about the Schedule of Analyst/ Institutional Investors Meet
General Update[Equirus Conference] Investor/analyst meets scheduled for 13-Aug-2026 at 09:00 and 12:00 IST in Mumbai -
The Board of Directors of the Company, at their meeting held today i.e. August 10,2026 inter alia, approved the Un-audit…
Financial ResultsPress Release - Q1FY27 - Total Income 126.94m, Net Profit 8.88m for Q1FY27 - Board approved 41st AGM on Sep 21, 2026 via VC/OAVM - Record date for div… -
Pursuant to Regulation 30 of the SEBI Listing Regulations, 2015, the Stock exchange is being informed that the Board of …
Financial ResultsQ1FY27 results: Standalone: Revenue 10.76bn +16% y-y (9.30bn) EBITDA margin 12.0% (11.6%) +40 bps y-y PAT -0.72bn loss vs 0.50bn profit y-y Consolidat… -
Please refer the attached Monitoring Agency Report for the quarter ended June 30, 2026.
Regulatory ComplianceMonitoring Agency Report for Q1 FY2026-27 submitted by Acuite Ratings. No deviation observed in utilization of preferential issue proceeds. Total proc… -
Intimation of Schedule of Earnings Call with Investors/Analysts
General UpdateQ1 FY2027 earnings call scheduled for 13-Aug-2026 at 09:30 IST -
Submission of outcome of Board Meeting held on 10/08/2026 has given approval for (1) Unaudited Financail Results for QE …
Financial ResultsPress Release - Q1FY27 - Approved unaudited financial results for Q1 ended 30.06.2026 - Recommended reappointment of Executive Director (Fin. & Comml.… -
Press Release
Financial ResultsPress Release - Q1FY27 - Revenue 1364cr +33% y-y; EBITDA 205cr +51% y-y (margin 15.1%, +190 bps); PAT 99cr +83% y-y - Growth driven by scale-up across… -
Outcome of Board Meeting
Financial ResultsQ1FY27 results (unaudited): Standalone: Revenue 1.104bn +7% y-y (1.029bn) PAT 95.8m +(not comparable) y-y (125.2m) Consolidated: Revenue 1.089bn -6% … -
Press Release - Declaration of Financial results for quarter ended 30th June, 2026
Financial ResultsPress Release - Q1FY27 - Revenue 45.86 Cr +18.1% y-y; Operating profit 11.88 Cr +40.9% y-y; PAT 9.20 Cr +20.2% y-y - Operating margin expanded 420 bps… -
Please find enclosed herewith details of the Earnings Conference Call with Analysts/Investors for the Financial Results …
General UpdateEarnings call for Q1 FY27 results scheduled on August 13, 2026 at 2:00 PM IST (invitation with MD & CFO). -
Please refer the attached intimation.
Regulatory ComplianceAmendment to the Code of Conduct for Prevention of Insider Trading approved by Board on August 10, 2026. The updated Code aligns with SEBI PIT Regulat… -
Disclosure under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Require…
General UpdateOne-on-one call held with Morgan Stanley on 10-Aug-2026 at 11:00 AM in Gurugram. Information shared was already public. -
Outcome of the meeting held on 10th August, 2026
Board MeetingBoard meeting to consider Q1FY27 and FY27 results Date: 10-Aug-2026 (Mon) - To consider dividend -
Outcome of 37th Annual General Meeting held today i.e 10th August 2026
Corporate ActionOutcome of 37th AGM held on 10-Aug-2026 - Audited financial statements for FY26 adopted - Dividend declared at Rs 1.50/share (15%) for FY26 - Mr. Swap… -
Please find attached Monitoring Agency Report for the Q1 FY27
Regulatory ComplianceMonitoring Agency Report for Q1 FY27 on IPO fund utilization - No deviation from IPO objects; delay in utilization timelines noted - Rs. 18.47 Cr used… -
Bagging/Receiving of orders/contracts
Corporate ActionBEL receives additional orders worth Rs.541 Crore since 31 July 2026 - Orders include communication equipment, electro optics, ammunition fuzes - Chem… -
Press Release - Declaration of Un-audited Financial Results for quarter ended 30th June, 2026
Financial ResultsPress Release - Q1FY27 - Revenue 45.86 Cr +18.1% y-y; Operating profit 11.88 Cr +40.9% y-y; PAT 9.20 Cr +20.2% y-y - Operating margin expanded 420 bps… -
Please find attached Clarification regarding typographical error in Consolidated Financials Results.
Financial ResultsFY2026 results: Standalone: Revenue 368.3bn +x% y-y (367.3bn) EBITDA 243.6bn +x% y-y (236.5bn) EBITDA margin 66.1% (64.2%) +190 bps y-y PAT 178.6bn +x… -
Press release on financial results for the quarter ended June 30, 2026
Financial ResultsPress Release - Q1FY27 - PBT rose 67% QoQ to INR 62 Cr; Disbursement grew 88% YoY - NIM expanded to 11.93% in Q1 FY27 from 10.29% in Q1 FY26 - Gross N… -
Reg 34_Annual Report
Financial ResultsFY2026 results (audited): Standalone: Revenue 7.3tn +54% y-y (4.7tn) EBITDA 1.1tn +57% y-y (0.7tn) EBITDA margin 14.9% (12.7%) +220 bps y-y PAT 0.59tn… -
Submissison of unaudited financial results for the first quarter ended 30.06.2026 along with Limited Review Report issue…
Financial ResultsPress Release - Q1FY27 - Revenue from operations 543.1 Cr +11% y-y; PAT 45.4 Cr +17% y-y - Chemicals segment revenue 536.6 Cr, Oils & Fats 9.4 Cr for … -
Please refer the attached intimation.
Financial ResultsPress Release - Q1FY27 - Total Income 511.36m +213% y-y; Net Profit 342.11m +244% y-y - No revenue from operations; growth driven by other income - EP… -
Linde India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2026 ,in…
Board MeetingBoard meeting to consider Q1FY26 results Date: 11-Aug-2026 (Tue) -
Utilisation of Funds
Regulatory ComplianceUtilisation of funds statement submitted for preferential equity issue raised on 23 June 2025 amounting to Rs. 417.03 Cr. No deviation or variation in… -
Announcement under Regulation 30 (LODR)- Reappointment of ID
Management Change🔁 LEADERSHIP REAPPOINTMENT — Zee Entertainment Enterprises Limited ID Announcement reappointed as Director / KMP -
Rumour Clarification from SAIL
Regulatory ComplianceRumour clarification: SAIL is exploring fund-raising options including FPO/QIP for capex, but it is at a preliminary stage and no formal disclosure un… -
Newspaper publication of financial results for the quarter ended 30.06.2026
Regulatory ComplianceNewspaper publication of financial results for Q1 FY27 (routine disclosure, no material impact) -
Intimation about analysts meet on 17th August 2026.
General UpdateAnalyst/investor group meeting scheduled for 17-Aug-2026 at 10:30 AM in Bangalore organized by Goldman Sachs. Discussion will cover publicly available… -
Intimation enclosed
Management ChangeChange in designation of Mr. Pankaj Malhan in subsidiary RHIMIRL - Appointed Chairman of RHIMIRL - Designation effective 10 August 2026 - New title: C…
Never miss a filing again
1
Sign in with Google
2
Add stocks to watchlist
3
Get instant Telegram alerts
14-day Pro trial included · No credit card required
About this page.
Indian Stock Alerts monitors BSE and NSE for corporate announcements every few minutes.
Each filing is downloaded, parsed, and summarised by AI. This page shows the latest
processed filings across all 5,000+ listed companies. Data sourced from public SEBI LODR
filings. Not investment advice.
Browse all companies →